Vistagen Therapeutics, Inc. Common Stock VTGN
$0.23
+1.13%
at last close
Financials (TTM)
- Revenue
- $1.27 million
- Net Income
- $-69,685,000
- Net Margin
- -5491.33%
- Return on Equity
- -196.19%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 0.27
- Price / Sales
- 7.53
Over the trailing twelve months, Vistagen Therapeutics, Inc. Common Stock generated revenue of $1.27 million and net income of $-69,685,000, a net margin of -5491.33%.
At the last closing price of $0.23, VTGN trades at 7.53 times sales, with a market capitalization of $9.55 million.
Key Stats
- Last Close
- $0.23
- Market Cap
- $9.55 million
- 52-Week Range
- $0.20 – $5.14
- Average Volume
- 3.39 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.